X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
lansoprazole (1251) 1251
humans (1117) 1117
science & technology (967) 967
life sciences & biomedicine (951) 951
male (848) 848
female (731) 731
2-pyridinylmethylsulfinylbenzimidazoles (679) 679
omeprazole - analogs & derivatives (657) 657
middle aged (583) 583
adult (582) 582
proton pump inhibitors (482) 482
gastroenterology & hepatology (457) 457
omeprazole - administration & dosage (428) 428
pharmacology & pharmacy (408) 408
helicobacter infections - drug therapy (385) 385
aged (374) 374
anti-ulcer agents - administration & dosage (337) 337
helicobacter pylori (312) 312
treatment outcome (304) 304
omeprazole - therapeutic use (297) 297
drug therapy, combination (296) 296
anti-ulcer agents - therapeutic use (276) 276
amoxicillin - administration & dosage (218) 218
clarithromycin - administration & dosage (207) 207
drug administration schedule (192) 192
anti-bacterial agents - administration & dosage (188) 188
2-pyridinylmethylsulfinylbenzimidazoles - administration & dosage (173) 173
omeprazole - pharmacology (165) 165
double-blind method (163) 163
gastroesophageal reflux - drug therapy (162) 162
helicobacter pylori - drug effects (160) 160
prospective studies (155) 155
adolescent (149) 149
animals (140) 140
medicine & public health (140) 140
abridged index medicus (136) 136
dose-response relationship, drug (136) 136
proton pump inhibitors - administration & dosage (134) 134
anti-bacterial agents - therapeutic use (130) 130
anti-ulcer agents - pharmacology (129) 129
omeprazole (129) 129
2-pyridinylmethylsulfinylbenzimidazoles - therapeutic use (128) 128
omeprazole - adverse effects (124) 124
rabeprazole (121) 121
cross-over studies (120) 120
clarithromycin - therapeutic use (119) 119
amoxicillin - therapeutic use (116) 116
proton pump inhibitor (115) 115
time factors (112) 112
administration, oral (111) 111
enzyme inhibitors - administration & dosage (109) 109
aged, 80 and over (108) 108
lansoprazole - administration & dosage (103) 103
proton pump inhibitors - therapeutic use (101) 101
drug interactions (96) 96
gastroesophageal reflux (96) 96
hydrogen-ion concentration (96) 96
omeprazole - pharmacokinetics (95) 95
anti-ulcer agents - adverse effects (94) 94
internal medicine (91) 91
peptic ulcer - drug therapy (91) 91
metronidazole - administration & dosage (89) 89
gastroenterology (85) 85
cytochrome p-450 cyp2c19 (84) 84
helicobacter infections - complications (83) 83
pantoprazole (81) 81
rats (78) 78
care and treatment (77) 77
dosage and administration (77) 77
enzyme inhibitors - therapeutic use (75) 75
follow-up studies (75) 75
medicine, general & internal (75) 75
proton pump inhibitors - adverse effects (75) 75
2-pyridinylmethylsulfinylbenzimidazoles - adverse effects (74) 74
anti-ulcer agents - pharmacokinetics (74) 74
drug therapy (74) 74
general & internal medicine (74) 74
young adult (73) 73
helicobacter infections - microbiology (71) 71
duodenal ulcer - drug therapy (70) 70
helicobacter pylori - isolation & purification (70) 70
stomach ulcer - drug therapy (70) 70
area under curve (68) 68
oncology (68) 68
proton pump inhibitors - pharmacology (68) 68
esomeprazole (66) 66
child (65) 65
gastric acidity determination (65) 65
pharmacology/toxicology (65) 65
genotype (64) 64
gastric acid - metabolism (63) 63
pharmacokinetics (63) 63
aryl hydrocarbon hydroxylases - genetics (59) 59
2-pyridinylmethylsulfinylbenzimidazoles - pharmacokinetics (58) 58
2-pyridinylmethylsulfinylbenzimidazoles - pharmacology (58) 58
enzyme inhibitors - pharmacology (58) 58
lansoprazole - therapeutic use (58) 58
peptic ulcer - microbiology (58) 58
hepatology (57) 57
research (57) 57
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1327) 1327
Japanese (88) 88
French (12) 12
Spanish (12) 12
German (11) 11
Russian (8) 8
Portuguese (6) 6
Chinese (3) 3
Korean (3) 3
Norwegian (2) 2
Czech (1) 1
Hungarian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gut, ISSN 0017-5749, 09/2016, Volume 65, Issue 9, pp. 1439 - 1446
ObjectiveThe objective of this study was to assess the efficacy, safety and tolerability of vonoprazan, a novel potassium-competitive acid blocker, as a... 
antibiotic therapy | clinical trials | Helicobacter pylori infection | helicobacter pylori - treatment | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Humans | Middle Aged | Helicobacter Infections - complications | Helicobacter pylori - drug effects | Male | Drug Monitoring - methods | Proton Pump Inhibitors - administration & dosage | Pyrroles - administration & dosage | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Metronidazole - adverse effects | Peptic Ulcer - diagnosis | Pyrroles - adverse effects | Adult | Female | Amoxicillin - administration & dosage | Anti-Bacterial Agents - adverse effects | Helicobacter Infections - diagnosis | Lansoprazole - administration & dosage | Proton Pump Inhibitors - adverse effects | Double-Blind Method | Drug Administration Schedule | Clarithromycin - adverse effects | Metronidazole - administration & dosage | Treatment Outcome | Drug Therapy, Combination - methods | Lansoprazole - adverse effects | Sulfonamides - adverse effects | Amoxicillin - adverse effects | Helicobacter pylori - isolation & purification | Anti-Bacterial Agents - administration & dosage | Peptic Ulcer - drug therapy | Breath Tests - methods | Peptic Ulcer - etiology | Sulfonamides - administration & dosage | Usage | Safety and security measures | Research | Helicobacter pylori | Antacids | Index Medicus | Abridged Index Medicus | Helicobacter Pylori | HELICOBACTER PYLORI - TREATMENT | CLINICAL TRIALS | 1506 | ANTIBIOTIC THERAPY | HELICOBACTER PYLORI INFECTION
Journal Article
Gut, ISSN 0017-5749, 11/2016, Volume 65, Issue 11, pp. 1784 - 1792
Journal Article
The Lancet (British edition), ISSN 0140-6736, 11/2016, Volume 388, Issue 10058, pp. 2355 - 2365
Summary Background Whether concomitant therapy is superior to bismuth quadruple therapy or 14-day triple therapy for the first-line treatment of Helicobacter... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Helicobacter pylori - drug effects | Male | Antacids - therapeutic use | Anti-Bacterial Agents - therapeutic use | Proton Pump Inhibitors - administration & dosage | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Organometallic Compounds - therapeutic use | Female | Urea - metabolism | Amoxicillin - administration & dosage | Lansoprazole - administration & dosage | Drug Administration Schedule | Metronidazole - administration & dosage | Breath Tests | Tetracycline - therapeutic use | Clarithromycin - therapeutic use | Proton Pump Inhibitors - therapeutic use | Amoxicillin - therapeutic use | Taiwan | Drug Therapy, Combination - statistics & numerical data | Lansoprazole - therapeutic use | Antacids - administration & dosage | Anti-Bacterial Agents - administration & dosage | Tetracycline - administration & dosage | Organometallic Compounds - administration & dosage | Clinical trials | Medical colleges | Helicobacter infections | Care and treatment | Helicobacter pylori | Antiulcer drugs | Analysis | Bacteria | Bacterial infections | Antibiotics | Drug resistance | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 07/2018, Volume 13, Issue 7, pp. e0199160 - e0199160
... and Drug Administration of the United States of America published a Drug Safety Communication on March 2, 2011 [8], stressing the risk for hypomagnesemia due to long... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Rabeprazole - adverse effects | Esomeprazole - administration & dosage | Humans | Middle Aged | Esomeprazole - adverse effects | Vascular Calcification - diagnostic imaging | Male | Aorta, Abdominal - diagnostic imaging | Proton Pump Inhibitors - administration & dosage | Vascular Calcification - etiology | Female | Retrospective Studies | Aorta, Abdominal - pathology | Aorta, Abdominal - metabolism | Kidney Failure, Chronic - physiopathology | Lansoprazole - administration & dosage | Proton Pump Inhibitors - adverse effects | Omeprazole - administration & dosage | Vascular Calcification - blood | Logistic Models | Omeprazole - adverse effects | Vascular Calcification - pathology | Computed Tomography Angiography | Disease Progression | Kidney Failure, Chronic - therapy | Lansoprazole - adverse effects | Kidney Failure, Chronic - blood | Aged | Magnesium - blood | Rabeprazole - administration & dosage | Renal Dialysis | CT imaging | Usage | Medical examination | Hemodialysis | Development and progression | Blood | Complications and side effects | Logistic regression | Proton pump inhibitors | Dosage and administration | Diagnosis | Cardiovascular diseases | Drug therapy | Calcification (ectopic) | Calcium | Medical records | Cardiovascular disease | Multivariate analysis | Urology | Peritoneal dialysis | Confidence intervals | Ethics | Computed tomography | Consent | Diuretics | Aorta | Magnesium | Hypomagnesemia | University graduates | Statistical analysis | Phosphorus | Regression analysis | Patients | Abdomen | Medicine | Studies | Hospitals | Coronary vessels | Calcification | Dialysis | Kidney diseases | Veins & arteries | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2013, Volume 381, Issue 9862, pp. 205 - 213
Journal Article